peptide vs semaglutide Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults Peptide of the Week: Semaglutide

What should I do if I experience severe nausea with semaglutide

Author Contributions Concept and design: John Bacon, Sommer Sekhon, Ibaadat Sukhmanii Kahlon Acquisition, analysis, or interpretation of data: John Bacon, Sommer Sekhon, Ibaadat Sukhmanii Kahlon Drafting of the manuscript: John Bacon, Sommer Sekhon, Ibaadat Sukhmanii Kahlon Supervision: John Bacon Critical review of the manuscript for important intellectual content: Ibaadat Sukhmanii Kahlon References 1.Ischaemic colitis: practical challenges and evidence-based recommendations for management

Perioperative Hyperglycemia Management: An Update

have shown that a peripheral injection of GLP-1, irrespective of its site of infusion (vena cava, intraperitoneal cavity, or portal vein), reduced food intake without affecting the subsequent inter-meal interval, the size of subsequent meals, or the cumulative food intake [88]